Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer
Oncogene
.
2022 Jun;41(26):3507-3509.
doi: 10.1038/s41388-022-02355-1.
Authors
Max A K Rätze
#
1
,
Thijs Koorman
#
1
,
Thijmen Sijnesael
1
,
Blessing Bassey-Archibong
2
,
Robert van de Ven
1
,
Lotte Enserink
1
,
Daan Visser
1
,
Sridevi Jaksani
1
,
Ignacio Viciano
3
,
Elvira R M Bakker
1
,
François Richard
4
,
Andrew Tutt
5
6
,
Lynda O'Leary
6
,
Amanda Fitzpatrick
6
,
Pere Roca-Cusachs
3
,
Paul J van Diest
1
,
Christine Desmedt
4
,
Juliet M Daniel
2
,
Clare M Isacke
6
,
Patrick W B Derksen
7
Affiliations
1
Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.
2
Department of Biology, McMaster University, Hamilton, ON, Canada.
3
Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute of Technology (BIST), Barcelona, Spain.
4
Laboratory for Translational Breast Cancer Research, Katholieke Universiteit, Leuven, Belgium.
5
The Breast Cancer Now Research Unit, King's College London, London, United Kingdom.
6
Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.
7
Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands. p.w.b.derksen@umcutrecht.nl.
#
Contributed equally.
PMID:
35610485
PMCID:
PMC9232389
DOI:
10.1038/s41388-022-02355-1
No abstract available
Publication types
Published Erratum
Grants and funding
MR/P001564/1/MRC_/Medical Research Council/United Kingdom